Literature DB >> 10399775

Transient hepatic attenuation difference (THAD) in patients without neoplasm: frequency, shape, distribution, and causes.

M Yamasaki1, A Furukawa, K Murata, R Morita.   

Abstract

Transient hepatic attenuation difference (THAD) is a valuable finding in detecting hypervascular lesions. However, similar findings are also observed in patients even without known hepatic diseases. We elucidate the characteristic findings and the causes of THAD in patients without hepatic neoplasm in this article. Dual-phased contrast-enhanced CT studies performed in 450 patients were reviewed, and THAD was observed in 42 (9.3%). THAD was linear or wedge-shaped and was seen contiguous to the liver surface with a relatively obscure margin in 40 of the 42 cases. The most common cause of THAD was chronic cholecystitis followed by previous biliary surgery. THAD was also seen in 30 patients with no hepatic diseases in whom it had a tendency to locate around the gallbladder fossa or in the periphery of the liver particularly in the left lobe. The knowledge of the prevalence, shape, distribution and causes of THAD is essential for the evaluation of contrast-enhanced CT images obtained during the arterial phase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399775

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  3 in total

1.  Capability of multidetector CT to diagnose hepatocellular carcinoma-associated arterioportal shunt.

Authors:  Ming-Yue Luo; Hong Shan; Zai-Bo Jiang; Wen-Wei Liang; Jian-Sheng Zhang; Lu-Fang Li
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

Review 2.  Hepatic perfusion disorders: etiopathogenesis and related diseases.

Authors:  Jin-Lin Tian; Jin-Shan Zhang
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

3.  Study on hepatocellular carcinoma-associated hepatic arteriovenous shunt using multidetector CT.

Authors:  Ming-Yue Luo; Hong Shan; Zai-Bo Jiang; Lu-Fang Li; Hui-Qing Huang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.